AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16216530 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex hormones among HT users
Number of subjects: 383
Study 14567818 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT) procedure
Number of subjects: 46
Study 14567818 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Burch colposuspension
Number of subjects: 46
Study 9170894 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc gluconate lozenges, administered every 2 hours for the duration of cold symptoms
Number of subjects: 0
Study 9170894 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenges, administered every 2 hours for the duration of cold symptoms
Number of subjects: 0
Study 8416062 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact target stimuli
Number of subjects: 0
Study 8416062 — intervention group
Group type: EXPERIMENTAL
Intervention: Degraded target stimuli (removing 33% of elements or overlaying a matrix of dots)
Number of subjects: 0
Study 8416062 — intervention group
Group type: EXPERIMENTAL
Intervention: Related targets
Number of subjects: 0
Study 8416062 — intervention group
Group type: EXPERIMENTAL
Intervention: Unrelated targets
Number of subjects: 0
Study 4025853 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate (0.4 mg/kg)
Number of subjects: 83
Study 4025853 — intervention group
Group type: COMPARATOR
Intervention: Thiopental (4 mg/kg)
Number of subjects: 83
Study 4025853 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl pretreatment (100 micrograms)
Number of subjects: 83
Study 4025853 — intervention group
Group type: COMPARATOR
Intervention: Normal saline pretreatment
Number of subjects: 83
Study 4025853 — intervention group
Group type: EXPERIMENTAL
Intervention: Both etomidate and thiopental
Number of subjects: 83
Study 31290696 — intervention group
Group type: EXPERIMENTAL
Intervention: Basketball training (2 hours, 5 days a week for 8 weeks)
Number of subjects: 0
Study 31290696 — intervention group
Group type: COMPARATOR
Intervention: Control group (adolescents who did not regularly exercise)
Number of subjects: 0
Study 31290696 — intervention group
Group type: EXPERIMENTAL
Intervention: Basketball training
Number of subjects: 0
Study 31499457 — intervention group
Group type: EXPERIMENTAL
Intervention: Active training condition (85-dB white noise burst paired with fearful faces)
Number of subjects: 144
Study 31499457 — intervention group
Group type: COMPARATOR
Intervention: Active control condition (white noise presented randomly)
Number of subjects: 144
Study 31499457 — intervention group
Group type: COMPARATOR
Intervention: No-sound condition
Number of subjects: 144
Study 28219426 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nepafenac 0.3%
Number of subjects: 1000
Study 28219426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 24690432 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic resistance training (FiO2 = 12.7%)
Number of subjects: 13
Study 24690432 — intervention group
Group type: COMPARATOR
Intervention: Normoxic resistance training (FiO2 = 20.9%)
Number of subjects: 13
Study 24690432 — intervention group
Group type: EXPERIMENTAL
Intervention: Both hypoxic and normoxic resistance training
Number of subjects: 13
Study 23932066 — intervention group
Group type: EXPERIMENTAL
Intervention: ropinirole PR
Number of subjects: 345
Study 23932066 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 345
Study 22117983 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat dextrin (15 g/day)
Number of subjects: 40
Study 22117983 — intervention group
Group type: COMPARATOR
Intervention: Placebo (15 g/day)
Number of subjects: 40
Study 19213680 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronedarone, 400 mg twice a day
Number of subjects: 4628
Study 19213680 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4628
Study 16838229 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitazoxanide (500 mg 2 times per day for 7 days)
Number of subjects: 104
Study 16838229 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitazoxanide (500 mg 2 times per day for 10 days)
Number of subjects: 104
Study 16838229 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole (250 mg 4 times per day for 10 days)
Number of subjects: 104
Study 12782840 — intervention group
Group type: EXPERIMENTAL
Intervention: Optic disc hemorrhage detection using stereo flicker chronoscopy of stereophotograph pairs
Number of subjects: 167
Study 12782840 — intervention group
Group type: COMPARATOR
Intervention: Global visual field indices, AGIS scores, intraocular pressures
Number of subjects: 167
Study 10855437 — intervention group
Group type: EXPERIMENTAL
Intervention: Amputee Mobility Aid (AMA)
Number of subjects: 0
Study 10855437 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical knee of the AMA
Number of subjects: 0
Study 10855437 — intervention group
Group type: COMPARATOR
Intervention: Pneumatic Post‐Amputation Mobility aid (PPAM aid)
Number of subjects: 0
Study 9109584 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment with headgear
Number of subjects: 0
Study 9109584 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment with modified bionator
Number of subjects: 0
Study 9109584 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 0
Study 8249589 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrobulbar bupivacaine block
Number of subjects: 32
Study 8249589 — intervention group
Group type: COMPARATOR
Intervention: Control group (no retrobulbar bupivacaine)
Number of subjects: 32
Study 3813141 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diazepam premedication
Number of subjects: 0
Study 3813141 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular diazepam premedication
Number of subjects: 0
Study 30615795 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 38
Study 30615795 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 38
Study 26810362 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Affirmed
Number of subjects: 85
Study 26810362 — intervention group
Group type: COMPARATOR
Intervention: Non-Affirmed
Number of subjects: 85
Study 24965823 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m²) once weekly for 4 weeks
Number of subjects: 52
Study 24965823 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 24965823 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 52
Study 22891881 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy‐Adolescent Skills Training (IPT‐AST)
Number of subjects: 98
Study 22891881 — intervention group
Group type: COMPARATOR
Intervention: School Counseling (SC)
Number of subjects: 98
Study 20179981 — intervention group
Group type: EXPERIMENTAL
Intervention: Avocado soybean unsaponifiable (Piascledine) 300 mg once daily
Number of subjects: 364
Study 20179981 — intervention group
Group type: COMPARATOR
Intervention: Chondroitin sulfate 400 mg three times daily
Number of subjects: 364
Study 20179981 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 364
Study 17334380 — intervention group
Group type: EXPERIMENTAL
Intervention: Panel of seven markers (ApoB3HVR-D3S1358-HUM-THO1-VWF-1-D16S310-FES-VWA)
Number of subjects: 1000
Study 17334380 — intervention group
Group type: EXPERIMENTAL
Intervention: Panel of seven markers
Number of subjects: 1000
Study 15869770 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate plus sulfadoxine-pyrimethamine (AS+SP)
Number of subjects: 161
Study 15869770 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate plus amodiaquine (AS+AQ)
Number of subjects: 161
Study 12539108 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate predictor derived from Cox regression analysis using patient age, sex, ejection fraction, smoking history, prior myocardial infarction history, frequency of premature beats, presence of runs of ventricular tachycardia on Holter monitoring, and time from index myocardial infarction to baseline Holter and recruitment into CAST.
Number of subjects: 200000
Study 9857355 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of 5, 10, 20 or 40 micrograms of a new hepatitis B vaccine
Number of subjects: 100
Study 9857355 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 20 micrograms of the vaccine
Number of subjects: 100
Study 9857355 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of 20 micrograms or 40 micrograms of the vaccine formulation
Number of subjects: 100
Study 9699448 — intervention group
Group type: COMPARATOR
Intervention: Vitremer
Number of subjects: 26
Study 9699448 — intervention group
Group type: COMPARATOR
Intervention: Dyract Ortho
Number of subjects: 26
Study 9699448 — intervention group
Group type: COMPARATOR
Intervention: Combined test materials (Vitremer and Dyract Ortho)
Number of subjects: 26
Study 9699448 — intervention group
Group type: COMPARATOR
Intervention: Control (Right-On)
Number of subjects: 26
Study 1882212 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie diet (approx. 25 calories/kg ideal body weight/day for 8 weeks)
Number of subjects: 12
Study 1882212 — intervention group
Group type: COMPARATOR
Intervention: Exchange list diet (approx. 25 calories/kg ideal body weight/day for 8 weeks)
Number of subjects: 12
Study 6812139 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 22
Study 6812139 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 22
Study 31818636 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC) applied by inflating a tourniquet on the thigh three times just after inducing anesthesia.
Number of subjects: 63
Study 31818636 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 63
Study 30816066 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic + COG
Number of subjects: 52
Study 30816066 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity + COG
Number of subjects: 52
Study 30816066 — intervention group
Group type: COMPARATOR
Intervention: Activity + Games
Number of subjects: 52
Study 28078523 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-branches autologous sling
Number of subjects: 120
Study 28078523 — intervention group
Group type: COMPARATOR
Intervention: Two-branches autologous sling
Number of subjects: 120
Study 23375997 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic disease management (CDM) intervention
Number of subjects: 60
Study 23375997 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study 21346593 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (3 months of vigorous aerobic exercise, supervised 3 times per week)
Number of subjects: 40
Study 21346593 — intervention group
Group type: COMPARATOR
Intervention: Nonaerobic (no aerobic exercise)
Number of subjects: 40
Study 19624554 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine (DL) 5 mg once daily
Number of subjects: 547
Study 19624554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 547
Study 19624554 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine (DL)
Number of subjects: 547
Study 18179991 — intervention group
Group type: EXPERIMENTAL
Intervention: Yearly IV bisphosphonate (zoledronic acid)
Number of subjects: 1174
Study 18179991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1174
Study 15100667 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (subcutaneous injections of a mixture of Dermatophagoides pteronyssinus and Dermatophagoides farinae vaccine; n=41)
Number of subjects: 72
Study 15100667 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=31)
Number of subjects: 72
Study 11430712 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral E2 6-11 microg/kg/d in the evening with GH 0.1 IU/kg/d sc at bedtime
Number of subjects: 9
Study 11430712 — intervention group
Group type: COMPARATOR
Intervention: Oral E2 6-11 microg/kg/d in the morning with GH 0.1 IU/kg/d sc at bedtime
Number of subjects: 9
Study 9209553 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g/kg alcohol dose
Number of subjects: 10
Study 9209553 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 g/kg alcohol dose
Number of subjects: 10
Study 9209553 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath alcohol concentrations
Number of subjects: 10
Study 9209553 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood alcohol concentrations
Number of subjects: 10
Study 8444538 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical phenytoin
Number of subjects: 75
Study 8444538 — intervention group
Group type: COMPARATOR
Intervention: Conventional saline dressings
Number of subjects: 75
Study 3695636 — intervention group
Group type: EXPERIMENTAL
Intervention: Modeling videotape with a patient asking questions
Number of subjects: 150
Study 3695636 — intervention group
Group type: EXPERIMENTAL
Intervention: Modeling videotape with a patient revealing problems
Number of subjects: 150
Study 3695636 — intervention group
Group type: COMPARATOR
Intervention: Control videotape with only the educator's presentation
Number of subjects: 150
Study 3695636 — intervention group
Group type: EXPERIMENTAL
Intervention: Both modeling conditions
Number of subjects: 150
Study 29406821 — intervention group
Group type: EXPERIMENTAL
Intervention: Goiter dispersion formula and antithyroid drugs (methimazole or propylthiouracil)
Number of subjects: 80
Study 29406821 — intervention group
Group type: COMPARATOR
Intervention: Antithyroid drug alone
Number of subjects: 80
Study 28606450 — intervention group
Group type: EXPERIMENTAL
Intervention: Hourly recorded messages in a family member's voice during waking hours over 3 ICU days
Number of subjects: 30
Study 28606450 — intervention group
Group type: EXPERIMENTAL
Intervention: Hourly recorded messages in a non-family voice during waking hours over 3 ICU days
Number of subjects: 30
Study 28606450 — intervention group
Group type: COMPARATOR
Intervention: No automated reorientation messages (control group)
Number of subjects: 30
Study 24847017 — intervention group
Group type: EXPERIMENTAL
Intervention: Biolimus-eluting stent (BES)
Number of subjects: 1161
Study 24847017 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 1161
Study 22840975 — intervention group
Group type: EXPERIMENTAL
Intervention: Midurethral sling surgery (retropubic and transobturator)
Number of subjects: 597
Study 22840975 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative urge incontinence
Number of subjects: 597
Study 22840975 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative urge incontinence
Number of subjects: 597
Study 20523044 — intervention group
Group type: EXPERIMENTAL
Intervention: PS-DHA
Number of subjects: 157
Study 20523044 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study 19211942 — intervention group
Group type: EXPERIMENTAL
Intervention: Arms-only swimming training (ES)
Number of subjects: 15
Study 19211942 — intervention group
Group type: COMPARATOR
Intervention: Control group (CS)
Number of subjects: 15
Study 15928361 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy plus standard treatment
Number of subjects: 103
Study 15928361 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 103
Study 12568062 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic Reading Through Dance program (20 sessions)
Number of subjects: 721
Study 12568062 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 721
Study 10584135 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiochemotherapy and amifostine (RCT + A)
Number of subjects: 47
Study 10584135 — intervention group
Group type: COMPARATOR
Intervention: Radiochemotherapy (RCT)
Number of subjects: 47
Study 8733931 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition that alerted participants to the gender of the names in Experiment 1
Number of subjects: 0
Study 8733931 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants' sex-role orientation in Experiment 2
Number of subjects: 0
Study 8733931 — intervention group
Group type: EXPERIMENTAL
Intervention: Process dissociation procedure used in both experiments
Number of subjects: 0
Study 1794297 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (2 g orally daily for 6 months)
Number of subjects: 200
Study 6844192 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine theophylline
Number of subjects: 0
Study 6844192 — intervention group
Group type: COMPARATOR
Intervention: Aminophylline
Number of subjects: 0
Study 30635256 — intervention group
Group type: EXPERIMENTAL
Intervention: Fronto-temporal tDCS (2-mA, twice-daily sessions for 5 days)
Number of subjects: 60
Study 29280483 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous 3,4-DAP
Number of subjects: 32
Study 29280483 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 27534747 — intervention group
Group type: EXPERIMENTAL
Intervention: Dydrogesterone 40 mg per os, followed by 10 mg per os three times a day until twelve completed weeks of gestation or 1 week after the bleeding has stopped, whichever is longer.
Number of subjects: 400
Study 27534747 — intervention group
Group type: COMPARATOR
Intervention: Placebo until twelve completed weeks of gestation or 1 week after the bleeding has stopped, whichever is longer.
Number of subjects: 400
Study 24833680 — intervention group
Group type: EXPERIMENTAL
Intervention: Day unit rehabilitation
Number of subjects: 306
Study 24833680 — intervention group
Group type: EXPERIMENTAL
Intervention: Home rehabilitation
Number of subjects: 306
Study 24833680 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional treatment)
Number of subjects: 306
Study 22228393 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based walking intervention
Number of subjects: 126
Study 22228393 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 126
Study 19636975 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambroxol (90 mg, three times per day for 3 months)
Number of subjects: 120
Study 19636975 — intervention group
Group type: COMPARATOR
Intervention: Control (no ambroxol treatment)
Number of subjects: 120
Study 19241647 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Number of subjects: 185
Study 19241647 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupuncture)
Number of subjects: 185
Study 16316362 — intervention group
Group type: EXPERIMENTAL
Intervention: IV iron sucrose (1 g in divided IV doses over 14 days)
Number of subjects: 0
Study 16316362 — intervention group
Group type: COMPARATOR
Intervention: Oral iron (ferrous sulfate, 325 mg orally thrice daily for 56 days)
Number of subjects: 0
Study 16316362 — intervention group
Group type: EXPERIMENTAL
Intervention: IV iron sucrose (200 mg IV over two to five minutes)
Number of subjects: 0
Study 12428232 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplantation (HSCT)
Number of subjects: 15
Study 9594486 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol xinafoate inhaled twice daily
Number of subjects: 0
Study 7648155 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic screening for abdominal aortic aneurysm (AAA)
Number of subjects: 15775
Study 7648155 — intervention group
Group type: COMPARATOR
Intervention: Age- and sex-matched controls (no screening)
Number of subjects: 15775
Study 2526364 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient treatment
Number of subjects: 459
Study 2526364 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment
Number of subjects: 459
Study 2526364 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 459
Study 941943 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen results reported (Group A)
Number of subjects: 622
Study 941943 — intervention group
Group type: COMPARATOR
Intervention: Estrogen results not reported (Group B)
Number of subjects: 622
Study 31574114 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (IV) infusion of 10 IU oxytocin
Number of subjects: 480
Study 31574114 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular (IM) injection of 10 IU oxytocin
Number of subjects: 480
Study 28065368 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)
Number of subjects: 300
Study 28065368 — intervention group
Group type: COMPARATOR
Intervention: Selective imaging practice (SIP)
Number of subjects: 300
Study 25583494 — intervention group
Group type: EXPERIMENTAL
Intervention: Environment and health-based information strategies
Number of subjects: 118
Study 25583494 — intervention group
Group type: COMPARATOR
Intervention: Monetary savings information
Number of subjects: 118
Study 23537587 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced toxicant prototype (RTP) cigarettes
Number of subjects: 0
Study 23537587 — intervention group
Group type: COMPARATOR
Intervention: Conventional cigarettes
Number of subjects: 0
Study 21723131 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait report group (N=90)
Number of subjects: 178
Study 19619427 — intervention group
Group type: EXPERIMENTAL
Intervention: ART restorations with cavity conditioner
Number of subjects: 48
Study 19619427 — intervention group
Group type: COMPARATOR
Intervention: ART restorations without cavity conditioning
Number of subjects: 48
Study 16842029 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocular correction modified through electromyographic control (study group)
Number of subjects: 32
Study 16842029 — intervention group
Group type: COMPARATOR
Intervention: Conventional ocular correction (control group)
Number of subjects: 32
Study 12970782 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon α (IFN)
Number of subjects: 199
Study 12970782 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyurea (HU)
Number of subjects: 199
Study 12970782 — intervention group
Group type: COMPARATOR
Intervention: Busulfan (BU)
Number of subjects: 199
Study 10869871 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma-hydroxybutyric acid
Number of subjects: 321
Study 10869871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 321
Study 8884582 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural relaxation training
Number of subjects: 20
Study 8884582 — intervention group
Group type: COMPARATOR
Intervention: Quiet reading period (Control)
Number of subjects: 20
Study 1543592 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle glycogen depletion (protocol 1)
Number of subjects: 17